Water

Water

SCHEMBL4106014

CCOC(=O)NS(=O)(=O)[N+](CC)(CC)CC.[OH-]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MGAM O43451 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
ALDH1A1 P00352 5/20 0.36
LMNA P02545 4/20 0.36
RECQL P46063 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 3/20 0.35
KDM4E B2RXH2 1/20 0.34
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL117889 0.84 EPHX1 (0.31) HPGD
Water SCHEMBL3635067 0.79
SCHEMBL5138578 0.74 GAA (0.46) GAASMN1; SMN2MGAMSIMGAM2
SCHEMBL3836989 0.73 GAA (0.44) GAASMN1; SMN2MGAMSIMGAM2
SCHEMBL9574919 0.73 GAA (0.44) GAASMN1; SMN2MGAMSIMGAM2
SCHEMBL5639931 0.73 GAA (0.46) GAASMN1; SMN2MGAMSIMGAM2
SCHEMBL23928061 0.71 GAA (0.42) GAASMN1; SMN2MGAMSIMGAM2
SCHEMBL529835 0.71 GAA (0.42) GAASMN1; SMN2MGAMSIMGAM2
SCHEMBL530163 0.71 FNTA (0.46) GAASMN1; SMN2MGAMSIMGAM2
SCHEMBL530162 0.71 GAA (0.42) GAASMN1; SMN2MGAMSIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286834-A1 Pyridine Analogues VI ASTRAZENECA AB (SE) 2009-11-19 US disclosed
US-20090186876-A1 Pyridine Analogues II ASTRAZENECA AB (SE) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286834-A1 Pyridine Analogues VI P2RY12, P2RY6, P2RY11 GAA 3542/4885SMN1; SMN2 3348/4885MGAM 3402/4885
US-20090186876-A1 Pyridine Analogues II P2RY12, P2RY11, P2RY6 GAA 3613/4885SMN1; SMN2 3657/4885MGAM 3173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.